By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
Episode Details
EPISODE INFO
- Released
- July 8, 2025
- Duration
- 11m
- Channel
- EO Studio
- Watch on YouTube
- ▶ Open ↗
EPISODE DESCRIPTION
This episode features HIS Challenge by BORYUNG – the pioneering space healthcare initiative connecting innovators with NASA and 40+ global partners. Since launching in 2022 with zero space experience and no network, HIS Challenge has grown from cold calls to collaborating with space agencies worldwide. BORYUNG, a Korean pharmaceutical company, began this journey when everyone said they were crazy. "What do you know about space?" was the common response. Yet they persisted, creating HIS Challenge to bridge healthcare and space. Today, their platform helps startups manufacture medicines in zero gravity that are impossible to make on Earth. Learn why they believe the future of medicine isn't down here, but 250 miles up, and how their platform makes space accessible to any startup bold enough to look beyond Earth's limits. 00:00 Intro 01:20 Building the Bridge to Space 05:05 Pioneers Join Our Mission 08:07 Now It's Your Turn 👉 Would you like to take part in space business and research? Apply now! https://form.jotform.com/251373800813048?utm_source=eo #spaceindustry #biotechnology EO stands for Entrepreneurship & Opportunities. As we're looking to feature more inspiring stories of entrepreneurs all over the world, don't hesitate to contact us at partner@eoeoeo.net X | @eostudi0 LinkedIn | @EO STUDIO Instagram | @eostudio.official Newsletter | https://www.eomag.io/subscribe?utm_source=youtube&utm_medium=description
EPISODE SUMMARY
In this episode of EO Studio, The Biggest Risk Is Not Taking Any Risk | HIS Challenge, BORYUNG explores Boryung’s Humans in Space Challenge connects biomed startups to space The video argues that space is becoming a practical R&D and manufacturing platform for biotech and pharma as launch costs fall dramatically and commercial space stations emerge.
RELATED EPISODES
